Cargando…

Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis

BACKGROUND: Addiction treatment and harm reduction services reduce risks of death and re-infection among patients with injection drug use-associated infective endocarditis (IDU-IE), but these are not offered at many hospitals. Among hospitalized patients with IDU-IE at the two tertiary-care hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brothers, Thomas D., Mosseler, Kimiko, Kirkland, Susan, Melanson, Patti, Barrett, Lisa, Webster, Duncan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791472/ https://www.ncbi.nlm.nih.gov/pubmed/35081174 http://dx.doi.org/10.1371/journal.pone.0263156

Ejemplares similares

Epidemiology, Microbiology, and Clinical Outcomes Among Patients With Intravenous Drug Use-Associated Infective Endocarditis in New Brunswick
por: Mosseler, Kimiko, et al.
Publicado: (2020)

Medical injection and access to sterile injection equipment in low- and middle-income countries: a meta-analysis of Demographic and Health Surveys (2010–2017)
por: Adewuyi, Emmanuel O, et al.
Publicado: (2019)

The opioid epidemic and endocarditis: Frontiers in the management of injection drug use–related endocarditis
por: Mori, Makoto, et al.
Publicado: (2021)

Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment
por: Ball, Laura J., et al.
Publicado: (2019)

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
por: Brothers, Thomas D., et al.
Publicado: (2022)

Caring for people who inject drugs when they are admitted to hospital
por: Brothers, Thomas D., et al.
Publicado: (2021)

A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
por: Kasper, Katherine J., et al.
Publicado: (2019)

Les soins hospitaliers aux personnes qui consomment des drogues injectables
por: Brothers, Thomas D., et al.
Publicado: (2021)

Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
por: Kasper, Katherine J., et al.
Publicado: (2019)

Importance of Opioid Agonist Therapy to Reduce Injection-Related Infections
por: Weaver, Victoria K, et al.
Publicado: (2022)

Breastfeeding on Injectable Opioid Agonist Therapy: A Case Report
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review
por: Brothers, Thomas D, et al.
Publicado: (2021)

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
por: Dobischok, Sophia, et al.
Publicado: (2022)

Sterile Endophthalmitis after Intravitreal Injections
por: Marticorena, Joaquín, et al.
Publicado: (2012)

Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study
por: Bardwell, Geoff, et al.
Publicado: (2023)

Promoting prosocial behavior in an unequal world
por: Kirkland, Kelly, et al.
Publicado: (2023)

Perinatal Injectable Opioid Agonist Therapy (iOAT) Administration: A Case Series
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Erratum to “Sterile Endophthalmitis after Intravitreal Injections”
por: Marticorena, Joaquín, et al.
Publicado: (2013)

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
por: Jaffe, Kaitlyn, et al.
Publicado: (2023)

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
por: Eydt, Erin, et al.
Publicado: (2021)

Recurrent Endocarditis in Persons Who Inject Drugs
por: Rodger, Laura, et al.
Publicado: (2019)

Brucella Endocarditis in Persons Who Inject Drugs
por: Cafardi, John M, et al.
Publicado: (2020)

Different drugs, different sides: injection use of opioids alone, and not stimulants alone, predisposes to right-sided endocarditis
por: Johnstone, Rochelle, et al.
Publicado: (2022)

High levels of interest in access to free safer smoking equipment to reduce injection frequency among people who inject drugs in Seattle, Washington
por: Reid, Molly C., et al.
Publicado: (2023)

Issues of Unequal Access to Public Health in India
por: Barik, Debasis, et al.
Publicado: (2015)

COVID-19 exacerbates unequal food access
por: Kar, Armita, et al.
Publicado: (2021)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

The Sterility and Potency of Injectable Substances: (i) Glucose Solutions
por: Pasricha, C. L., et al.
Publicado: (1941)

The Sterility and Potency of Injectable Substances: (iii) Cholera Vaccines
por: Pasricha, C. L., et al.
Publicado: (1941)

Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions
por: Bouck, Zachary, et al.
Publicado: (2022)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
por: Naggie, Susanna, et al.
Publicado: (2019)

Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis
por: Marks, Charles, et al.
Publicado: (2019)

Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis
por: Kimmel, Simeon D., et al.
Publicado: (2020)

Intracutaneous Injections of Sterile Water over the Secrum for Labour Analgesia
por: Saxena, Kirti N, et al.
Publicado: (2009)

Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2014)

The Sterility and Potency of Injectable Substances: (ii) Salines for Intravenous Use
por: Pasricha, C. L., et al.
Publicado: (1941)

Inadvertent sterile water injection in the epidural space: history revisited
por: Dwivedi, Deepak, et al.
Publicado: (2020)

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance
por: Meyers-Pantele, Stephanie A., et al.
Publicado: (2022)

People who inject oral morphine favor experimentation with injectable opioid substitution
por: Bertin, Célian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_an2bkr0ei46be7diesnog2ohdr